We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

128 hedge funds and large institutions have $447M invested in Array Biopharma Inc in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

51% less call options, than puts

Call options by funds: $396K | Put options by funds: $809K

Holders
128
Holders Change
+128
Holders Change %
–
% of All Funds
4.18%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.13%
New
128
Increased
–
Reduced
–
Closed
–
Calls
$396K
Puts
$809K
Net Calls
-$413K
Net Calls Change
-$413K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$2.64M +$3.12M +580,542 New
NI
27
Numeric Investors
Massachusetts
$2.6M +$3.08M +571,891 New
Balyasny Asset Management
28
Balyasny Asset Management
Illinois
$2.53M +$3M +557,940 New
Invesco
29
Invesco
Georgia
$2.48M +$2.94M +546,443 New
AQR Capital Management
30
AQR Capital Management
Connecticut
$2.47M +$2.93M +544,218 New
OAM
31
Oxford Asset Management
United Kingdom
$2.44M +$2.89M +536,646 New
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$2.43M +$2.88M +535,083 New
Citadel Advisors
33
Citadel Advisors
Florida
$2.38M +$2.82M +524,699 New
CGT
34
Capital Guardian Trust
California
$2.27M +$2.69M +500,000 New
TCIM
35
TIAA CREF Investment Management
New York
$2.21M +$2.62M +487,485 New
Geode Capital Management
36
Geode Capital Management
Massachusetts
$2.17M +$2.57M +478,058 New
Lord, Abbett & Co
37
Lord, Abbett & Co
New Jersey
$2.13M +$2.52M +468,799 New
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$2.04M +$2.42M +450,000 New
SCM
39
Suffolk Capital Management
New York
$1.63M +$1.93M +359,113 New
PAM
40
Panagora Asset Management
Massachusetts
$1.57M +$1.86M +346,130 New
B
41
Bailard
California
$1.48M +$1.75M +325,000 New
BIM
42
BlackRock Investment Management
Delaware
$1.41M +$1.67M +310,691 New
SGAM
43
Smith Group Asset Management
Texas
$1.38M +$1.64M +304,657 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$1.33M +$1.58M +293,560 New
Charles Schwab
45
Charles Schwab
California
$1.29M +$1.47M +272,450 New
Wellington Management Group
46
Wellington Management Group
Massachusetts
$1.23M +$1.46M +271,881 New
SONJCPFA
47
State of New Jersey Common Pension Fund A
New Jersey
$1.2M +$1.43M +265,000 New
WMSA
48
Weiss Multi-Strategy Advisers
New York
$1.18M +$1.4M +260,000 New
TD Asset Management
49
TD Asset Management
Ontario, Canada
$1.02M +$1.21M +224,100 New
Millennium Management
50
Millennium Management
New York
$1M +$1.19M +220,846 New
1
2
3 4 5

ARRY Hedge Fund Activity: Q2 2013 in Review

128 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q2 2013, worth a combined $447M.

Buyers outnumbered sellers: 128 funds opened new ARRY positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.

  • 128 institutional investors held Array Biopharma Inc (ARRY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $447M of Array Biopharma Inc stock for Q2 2013.
  • 128 funds opened new Array Biopharma Inc positions in Q2 2013 and 0 closed out, a net change of +128 holders.

Based on aggregated 13F filings for Q2 2013.